Ribociclib
Kisqali
返回商品目录Kisqali（ribociclib）是一种靶向药物，用于治疗激素受体阳性（HR+）、HER2阴性（HR+ HER2-）乳腺癌，尤其适用于早期（高危）或晚期/转移性病例。它需与内分泌治疗（芳香化酶抑制剂或氟维司群）联合使用，以抑制癌细胞生长。
有效成分
Kisqali 200mg
3 个套装| 包装 | 每片 | 特惠价 | Buy |
|---|---|---|---|
5
pills 免运费 | $117.00 | 仅需 $585.00 | |
3
pills 免运费 | $129.67 | 仅需 $389.00 | |
1
pills | $193.00 | 仅需 $193.00 |
您可能还喜欢
Kisqali is a targeted therapy used to treat hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer, specifically for advanced or metastatic cases or early-stage (II or III) high-risk cases. It is a CDK4/6 inhibitor that blocks proteins encouraging cancer growth.